Latest news with #ForeignCurrencyConvertibleBonds
India.com
6 days ago
- Business
- India.com
This company shares hit upper circuit post this important update
Shares of Elitecon International hit a 5 per cent upper circuit on Thursday, June 26, 2025. The upper circuit, a trading limit set by the stock exchange, prevented further buying in the stock due to the surge in demand. The counter opened gap up in the green at Rs 58.70, with a gain of 4.54 per cent from the previous close of Rs 56.15. The stock gained further to hit the upper circuit of Rs 58.95. The 52-week high of the stock is Rs 62.96 and the 52-week low is Rs 1.10. The market cap of the company is Rs 9,415.17. The scrip has been gaining for the last four days and has risen 19.36 per cent in this period. Share Price History The stock has given a multibagger return of 5,509 per cent in three years, indicating a significant growth in value over this period. In the last six months, it has risen by 514 per cent, and it has already gained 467 per cent so far this year. Company To Raise Funds The company has announced its intention to raise funds of up to Rs 75 crore from the public markets via a preferential allotment, a move that will significantly boost its financial position. 'To discuss and evaluate the proposal for raising funds up to an amount of ₹75 crores by way of preferential allotment, issue of convertible warrants, Foreign Currency Convertible Bonds (FCCBs), Qualified Institutional Placement (QIP) or any other permissible instruments/modes, subject to necessary approvals from Shareholders, regulatory bodies and other stakeholders,' the filing reads. Meanwhile, the equity benchmark indices Sensex and Nifty continued their winning streak in early trade on Thursday, buoyed by optimism following a ceasefire between Iran and Israel. The 30-share BSE Sensex climbed 163.27 points to 82,918.78 in early trade. The 50-share NSE Nifty went up 64.35 points to 25,309.10. Later, the BSE benchmark traded 415.98 points higher at 83,171.49, and the Nifty quoted 115.50 points up at 25,359.45.
Mint
6 days ago
- Business
- Mint
5,000% rally in one year! Multibagger small-cap stock to be in focus on Thursday after fundraise move
Multibagger small-cap stock: Elitecon International Limited's board of directors announced on Wednesday, 25 June 2025, that the company is set to raise ₹ 75 crore from the public markets via a preferential allotment, according to an exchange filing. Stock market investors will focus on the company's shares on Thursday, 26 June 2025. According to the BSE filing data, the company will use preferential allotment, the issue of convertible warrants, foreign currency convertible bonds (FCCBs), Qualified Institutional Placement (QIP), or any other permissible instruments for the fundraising plan. 'To discuss and evaluate the proposal for raising funds up to an amount of ₹ 75 crores by way of preferential allotment, issue of convertible warrants, Foreign Currency Convertible Bonds (FCCBs), Qualified Institutional Placement (QIP) or any other permissible instruments/modes, subject to necessary approvals from Shareholders, regulatory bodies and other stakeholders,' said Elitecon International in its exchange filing. Elitecon International is a tobacco manufacturer which supplies multiple products like smoking mixture, cigarettes, and flavoured molesis tobacco, among other tobacco products for both domestic and international markets. Elitecon International shares closed 4.95 per cent higher at ₹ 56.15 after Wednesday's stock market session, compared to ₹ 53.50 in the previous market close. The company announced the fundraising plans after market operating hours on 25 June 2025. Shares of the tobacco product maker have given stock market investors more than 4,000 per cent returns on investment in the last five years, and 5,004.55 per cent in the last one-year period. On a year-to-date (YTD) basis, the shares of Elitecon International are trading 441.47 per cent higher in 2025 and 52.46 per cent higher in the last one-month period. Elitecon International shares hit their 52-week high level at ₹ 62.96 on 10 June 2025, while the 52-week low level was at ₹ 1.10 on 26 August 2024, according to BSE data. The shares are trading lower than their year-high levels. The company's market capitalisation (M-Cap) was at ₹ 8,975.58 crore as of the stock market close on Wednesday, 25 June 2025. Read all stories by Anubhav Mukherjee Disclaimer: This story is for educational purposes only. The views and recommendations above are those of individual analysts or broking companies, not Mint. We advise investors to check with certified experts before making any investment decisions.
United News of India
23-06-2025
- Business
- United News of India
Sampre Nutritions Ltd Plans Strategic Fundraising Initiative to Drive Growth and Expansion
New Delhi [India], June 21: Sampre Nutritions Ltd (BSE: 530617), a leading confectionery manufacturer, has proposed fund raising initiative through various modes such as preferential issue. Communicated earlier this year to BSE, the company is likely to hold Board of Directors meeting in near future, for the shareholders to consider and approve plans for raising funds via issuance of eligible securities. The proposed capital raise may involve issuance of eligible securities of the company, in one or more ways, through public and/or private offerings, including by way of preferential issue, qualified institutions placement and / or further public offering, subject to such approvals as may be required, including approval of the shareholders of the Company. The aim is to strengthen the company's financial structure and support its ongoing expansion and diversification efforts. The management of the company commented 'This is an important step in our journey as we explore ways to expand operations, extend market penetration, and invest in long-term growth. The fundraising initiative highlights our commitment towards building a stronger, more resilient future at Sampre Nutritions Limited' As part of the process, the Board will also consider convening an Extraordinary General Meeting (EGM) or initiating a postal ballot to seek shareholder approval. Earlier in April 2024, the company successfully allotted 17 lakh equity shares at Rs 36 each following the conversion of warrants issued on a preferential basis. On October 14, 2024, the Board approved the conversion of 85 Foreign Currency Convertible Bonds (FCCBs), originally allotted on June 28, 2024, into equity shares. This resulted in the allotment of 1,19,42,116 fully paid-up equity shares of face value of Rs 10 at a conversion price of Rs 59.84 per share, increasing the company's paid-up capital to Rs. 2.09 crore comprising of 20,91,212 equity shares of face value of Rs. 10 each. Subsequently, in October 2024, the company received in-principle approval from BSE for listing of 89,91,711 equity shares of face value of Rs 10 each at a price of Rs 59.84 per equity share. Along with this, the company also received approval for issuance of 10,00,000 warrants convertible into equity shares of face value of Rs 10 each at a price of Rs 60.50 per equity share on a preferential basis. In November 2024, the company approved the allotment of 8,40,000 warrants on a preferential basis to non-promoters at a price of Rs 60.50 per warrant, each convertible into one equity share of face value Rs 10. The company was also awarded the Certificate of Recognition under the India 5000 Best MSME Awards 2024 for excellence in quality, customer satisfaction, and societal impact. The company recently announced its Q4 FY25 and FY25 consolidated financial result. The consolidated revenue from operations remained stable at Rs 25.12 crore. The company reported a consolidated net loss of Rs 7.67 crore, mainly on account of investment into subsidiaries and higher finance costs. For Q4 FY25, company reported revenue of Rs 7.76 crore, a growth from Rs 4.76 crores reported in Q4 FY24. About Sampre Nutritions Ltd: Incorporated in 1991 and headquartered in Medchal, Telangana, Sampre Nutritions Ltd is engaged in manufacturing complete range of confectionery, éclairs, candies, lollipops, toffees, powder and centre filled products. The company is instrumental to deliver the growing volumes for most of the MNC's and beside producing its own brand. The group is one stop shop for complete range of confectionary productions. It has multiple MNC's as their clients as Mondelez India Pvt Ltd, Perfetti Van Melle, Reliance, DS Group, Nestle to name a few… The promoter is also the President for Indian Confectionery Manufacturers Association and is into the industry for the past 4 decades Sampre Nutrition is the first ISO certified company in South East Asia in this category since 1995 and is the 1st HACCP Certified Company by BVQI and FSSA Version 6 certified company with receiving Multiple Quality Awards World Wide. Further the company is associated with Mondelez India Pvt Ltd for manufacturing Eclairs for the past 30 Years and the Sole Manufacturer for Eclairs for the past 8 years for India, China and South African Market.
Business Standard
21-06-2025
- Business
- Business Standard
Sampre Nutritions Ltd Plans Strategic Fundraising Initiative to Drive Growth and Expansion
PNN New Delhi [India], June 21: Sampre Nutritions Ltd (BSE: 530617), a leading confectionery manufacturer, has proposed fund raising initiative through various modes such as preferential issue. Communicated earlier this year to BSE, the company is likely to hold Board of Directors meeting in near future, for the shareholders to consider and approve plans for raising funds via issuance of eligible securities. The proposed capital raise may involve issuance of eligible securities of the company, in one or more ways, through public and/or private offerings, including by way of preferential issue, qualified institutions placement and / or further public offering, subject to such approvals as may be required, including approval of the shareholders of the Company. The aim is to strengthen the company's financial structure and support its ongoing expansion and diversification efforts. The management of the company commented "This is an important step in our journey as we explore ways to expand operations, extend market penetration, and invest in long-term growth. The fundraising initiative highlights our commitment towards building a stronger, more resilient future at Sampre Nutritions Limited" As part of the process, the Board will also consider convening an Extraordinary General Meeting (EGM) or initiating a postal ballot to seek shareholder approval. Earlier in April 2024, the company successfully allotted 17 lakh equity shares at Rs 36 each following the conversion of warrants issued on a preferential basis. On October 14, 2024, the Board approved the conversion of 85 Foreign Currency Convertible Bonds (FCCBs), originally allotted on June 28, 2024, into equity shares. This resulted in the allotment of 1,19,42,116 fully paid-up equity shares of face value of Rs 10 at a conversion price of Rs 59.84 per share, increasing the company's paid-up capital to Rs. 2.09 crore comprising of 20,91,212 equity shares of face value of Rs. 10 each. Subsequently, in October 2024, the company received in-principle approval from BSE for listing of 89,91,711 equity shares of face value of Rs 10 each at a price of Rs 59.84 per equity share. Along with this, the company also received approval for issuance of 10,00,000 warrants convertible into equity shares of face value of Rs 10 each at a price of Rs 60.50 per equity share on a preferential basis. In November 2024, the company approved the allotment of 8,40,000 warrants on a preferential basis to non-promoters at a price of Rs 60.50 per warrant, each convertible into one equity share of face value Rs 10. Highlights: -Board to consider multiple fundraising paths, including QIP, preferential issue and others -Financial results for FY25 show revenue stability at Rs 25.12 crores -The company was awarded the Certificate of Recognition under the India 5000 Best MSME Awards 2024 for QUALITY EXCELLENCE The company was also awarded the Certificate of Recognition under the India 5000 Best MSME Awards 2024 for excellence in quality, customer satisfaction, and societal impact. The company recently announced its Q4 FY25 and FY25 consolidated financial result. The consolidated revenue from operations remained stable at Rs 25.12 crore. The company reported a consolidated net loss of Rs 7.67 crore, mainly on account of investment into subsidiaries and higher finance costs. For Q4 FY25, company reported revenue of Rs 7.76 crore, a growth from Rs 4.76 crores reported in Q4 FY24. About Sampre Nutritions Ltd: Incorporated in 1991 and headquartered in Medchal, Telangana, Sampre Nutritions Ltd is engaged in manufacturing complete range of confectionery, eclairs, candies, lollipops, toffees, powder and centre filled products. The company is instrumental to deliver the growing volumes for most of the MNC's and beside producing its own brand. The group is one stop shop for complete range of confectionary productions. It has multiple MNC's as their clients as Mondelez India Pvt Ltd, Perfetti Van Melle, Reliance, DS Group, Nestle to name a few... The promoter is also the President for Indian Confectionery Manufacturers Association and is into the industry for the past 4 decades Sampre Nutrition is the first ISO certified company in South East Asia in this category since 1995 and is the 1st HACCP Certified Company by BVQI and FSSA Version 6 certified company with receiving Multiple Quality Awards World Wide. Further the company is associated with Mondelez India Pvt Ltd for manufacturing Eclairs for the past 30 Years and the Sole Manufacturer for Eclairs for the past 8 years for India, China and South African Market.
Mint
20-06-2025
- Business
- Mint
Small-cap stock below ₹50 hits upper circuit following stock market rally
Stock Market Today: Small-cap stock below ₹ 50 hits upper circuit following stock market rally. Small-cap stock below ₹ 50 Sampre Nutrition announced its plans for a strategic fundraising initiative to drive growth and expansion. As per Sampre Nutrition media release highlights, the board is to consider multiple fundraising paths, including QIP, preferential issue, and others The company is expected to host a Board of Directors meeting soon to allow shareholders to review and approve plans for raising money through the issuing of suitable securities, as was communicated to the BSE earlier this year. Leading candy manufacturer Sampre Nutritions Ltd. has suggested a fund-raising campaign using a variety of strategies, including preferential issuance. The objective is to strengthen the company's financial structure and support its ongoing expansion and diversification efforts. Sampre Nutritions management in a statement, said that "This is an important step in our journey as we explore ways to expand operations, extend market penetration, and invest in long-term growth. The fundraising initiative highlights our commitment towards building a stronger, more resilient future at Sampre Nutritions Limited" As part of the process, the Board will also consider convening an Extraordinary General Meeting (EGM) or initiating a postal ballot to seek shareholder approval A year back, in the month of April 2024, the company successfully allotted 17 lakh equity shares at ₹ 36 each following the conversion of warrants issued on a preferential basis. The Board also had approved the conversion of 85 Foreign Currency Convertible Bonds (FCCBs), which were initially issued on June 28, 2024, into equity shares on October 14, 2024. Small-cap stock below ₹ 50: Sampre Nutrition share price opened at ₹ 30.60, 2% higher than the previous day's closing price of ₹ 30. Since ₹ 30.60 was the upper price band, the Sampre Nutrition share price was locked in an upper circuit.
